HERVOLUTION
LIVE

Serial Number

98393796

Owner

InProTher ApS

Attorney

Margaret C. McHugh

Filing Date

Feb 6, 2024

Add to watchlist:

No watchlists yet
View on USPTO

HERVOLUTION Trademark

Serial Number: 98393796 • Registration: 7854817

HERVOLUTION is a trademark filed by InProTher ApS on February 6, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

InProTher ApS (2 trademarks)

Ole Maaloes Vej 3
Copenhagen 2200 , DK

Entity Type: 99

Trademark Details

Filing Date

February 6, 2024

Registration Date

July 8, 2025

Published for Opposition

May 20, 2025

Goods & Services

Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary use, namely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline; Viral-based immunotherapeutics being pharmaceutical preparations, in particular for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS, and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline

Business management, organization and administration; business management of licences for pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; retail store and wholescale store services, and online retail store and wholesale store services, in the field of pharmaceuticals, vaccines and medicines, such as viral- based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases

Research and development of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; medical, biological, and scientific research relating to the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases, in particular via immunotherapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 14, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 22, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 22, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 22, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 30, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 4, 2024 NWOS
NEW APPLICATION ENTERED
Feb 6, 2024 NWAP